Apalutamide Study Prioritized For Non-Metastatic Canstrate-Resistant Prostate Cancer

Men with non-metastatic castrate-resistant prostate cancer will soon know whether or not apalutamide is helpful.  The USA based Food and Drug Administration has cut the review time from ten to six months.   We might hear the FDA's ruling as early as April, 2018. Apalutamide (ARN-509) is an  androgen receptor inhibitor and might prove to [...]

By |2018-01-08T14:36:05-05:00January 8th, 2018|Advanced Prostate Cancer|1 Comment

Exercise and Advanced Prostate Cancer

Exercise of any kind helps men at any stage of Prostate Cancer.   Unfortunately, many advanced stage prostate cancer patients don't exercise enough. Advanced Prostate Cancer patients worry about bone pain more than other men.  Androgen deprivation therapy, commonly called "hormone therapy," can cause bone problems.  Metastases to bones can cause severe pain that many [...]

By |2020-02-04T12:33:09-05:00January 5th, 2018|Advanced Prostate Cancer|0 Comments

Changing a Protein Might Stop Metastases

How cool is this?  What if we can change how fast and far prostate cancer cells can metastasize by changing a single protein. The lead article in this months Oncotarget describes how prostate cancer moves in our bodies, and what we might be able to do to prevent metastatic cancer. Epithelial-to-mesenchymal transition (EMT) is [...]

By |2020-02-04T12:35:00-05:00November 21st, 2017|Advanced Prostate Cancer|0 Comments
Go to Top